US nod for Meridian's OrthoView software:
This article was originally published in Clinica
Meridian Technique has received FDA 510 (k) approval to market its orthopaedic surgery planning software in the US. The software, called OrthoView, allows surgeons to manipulate digital images to decide what implant or prosthesis to use for a patient and where to place it. The system also records data for each patient and is designed for use on a picture archiving communication system (PACS). The Southampton, UK-based firm's software is already in use in Europe and many countries around the world.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.